These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16297366)

  • 1. Natriuretic peptides: novel therapeutic targets in heart failure.
    Cataliotti A; Burnett JC
    J Investig Med; 2005 Nov; 53(7):378-84. PubMed ID: 16297366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides and remodeling in heart failure.
    Burnett JC
    Heart Fail Clin; 2005 Apr; 1(1):129-39. PubMed ID: 17386839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renin-angiotensin-aldosterone system and natriuretic peptide system--reference to cardiovascular diseases].
    Yasue H; Mizuno Y; Harada E; Ito T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():164-9. PubMed ID: 15506362
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptide system and the heart.
    Del Ry S; Cabiati M; Clerico A
    Front Horm Res; 2014; 43():134-43. PubMed ID: 24943304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential future therapies: natriuretic peptides.
    Lisy O; Burnett JC
    Coron Artery Dis; 1999 Sep; 10(6):389-94. PubMed ID: 10474789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.
    McKie PM; Burnett JC
    Curr Heart Fail Rep; 2015 Feb; 12(1):7-14. PubMed ID: 25331110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer natriuretic peptides: a vision for the future of heart failure therapeutics.
    Zakeri R; Burnett JC
    Can J Physiol Pharmacol; 2011 Aug; 89(8):593-601. PubMed ID: 21815778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic directions for the natriuretic peptides in cardiovascular diseases: what's on the horizon.
    Burnett JC
    J Cardiol; 2006 Nov; 48(5):235-41. PubMed ID: 17136818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corin: a new player in the regulation of salt-water balance and blood pressure.
    Armaly Z; Assady S; Abassi Z
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):713-22. PubMed ID: 24100222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides and salt sensitivity: endocrine cardiorenal integration in heart failure.
    Villarreal D; Freeman RH; Reams GP
    Congest Heart Fail; 2002; 8(1):29-36, 48. PubMed ID: 11821626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure.
    Krupicka J; Janota T; Kasalová Z; Hradec J
    Physiol Res; 2009; 58(2):171-177. PubMed ID: 18380534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of natriuretic peptides in heart failure.
    de Sa DD; Chen HH
    Curr Cardiol Rep; 2008 May; 10(3):182-9. PubMed ID: 18489861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
    Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M
    Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential for existing and novel forms of natriuretic peptides.
    Chen HH; Burnett JC
    Heart Fail Clin; 2006 Jul; 2(3):365-73. PubMed ID: 17386905
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure.
    Chee KH; Amudha K; Hussain NA; Haizal HK; Choy AM; Lang CC
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):140-8. PubMed ID: 14608517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natriuretic peptides--their receptors and role in cardiovascular system].
    Jerczyńska H; Pawłowska Z
    Postepy Biochem; 2008; 54(1):35-42. PubMed ID: 18610580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of renal hyporesponsiveness to BNP in heart failure.
    Egom EE; Feridooni T; Hotchkiss A; Kruzliak P; Pasumarthi KB
    Can J Physiol Pharmacol; 2015 Jun; 93(6):399-403. PubMed ID: 25881664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.